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Homocysteine (tHcy) is a sulfur-containing amino 
acid derived from dietary methionine; its levels are nor-
mally maintained within a narrow range by the activ-
ity of  remethylation and transsulfuration (1). Elevated 
fasting plasma tHcy concentrations are considered a 
biomarker of  increased oxidative stress, which is associ-
ated with an increased risk for endothelial damage and 
infl ammatory vascular processes (2, 3). Moreover, tHcy 
has been suggested to be a continuous independent and 
modifi able risk factor for several multi-system diseases 
including cardiovascular diseases (4) and stroke (5); 
dementia and Alzheimer’s disease (6); and osteoporotic 
fracture (7).
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Summary We examined the association of  physical activity (PA), cardiovascular fi tness 
(CVF) and fatness with total homocysteine (tHcy) concentrations in European adolescents. 
The present study comprised 713 European adolescents aged 14.81.2 y (females 55.3%) 
from the multicenter HELENA cross-sectional study. PA was assessed through accelerometry, 
CVF by the 20-m shuttle run test, and body fat by skinfold thicknesses with the Slaughter 
equation. Plasma folate, cobalamin, and tHcy concentrations were measured. To examine 
the association of  tHcy with PA, CVF, and fatness after controlling for a set of  confound-
ers including age, maturity, folate, cobalamin, creatinine, smoking, supplement use, and 
methylenetetrahydrofolate reductase 677 genotype (CC 47%, CT 43%, TT 10%), bivariate 
correlations followed by multiple regression models were performed. In the bivariate corre-
lation analysis, tHcy concentrations were slightly negatively correlated (p0.05) with CVF 
in females (measured both by stages: r0.118 and by VO2max: r0.102) and positively 
with body mass index (r0.100). However, daily time spent with moderate and vigorous 
PA showed a weak positive association with tHcy in females (p0.05). tHcy concentrations 
showed a tendency to decrease with increasing CVF and increase with increasing BMI in 
female European adolescents. However, tHcy concentrations were positively associated with 
moderate and vigorous PA in female European adolescents.
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Individual tHcy concentrations depend on non-com-
municable factors such as age and gender, showing 
higher levels in males than females and in older than 
in younger populations (8, 9). In addition, the common
C677T polymorphism of  the 5,10-methylenetetra-
hydrofolate reductase (MTHFR) gene, which regu-
lates folate metabolism involved in folate-dependent 
remethyl ation of  Hcy, has been established as an impor-
tant genetic determinant of  elevated Hcy (10, 11).
Lifestyle factors such as excessive alcohol intake, 
smoking, extenuating physical activity, and hyper-ener-
getic nutrition resulting in obesity as well as folate and 
vitamin B12 defi ciencies, can increase tHcy above ade-
quate concentrations (12–14).
Although it is well established that physical activity 
(PA) is a key component of  good health and disease pre-
vention both in adults (15) and in children and adoles-
cents (16, 17), there have been contradictory reports 
regarding its effects on plasma Hcy, without the type 
of  exercise or intensity to cause changes in tHcy being 
well defi ned (18, 19). However, PA of  moderate and 
high intensities (758 min per week) could increase 
tHcy concentrations due to elevated vitamin require-
ments (20). These divergences could be due to the dif-
ferent techniques used for evaluation of  PA, including 
self-reported questionnaires, the lack of  consideration 
of  intensity or duration of  PA, limited statistical power 
with small sample size, and no adjustment for the poten-
tial confounders (4).
Studies examining the possible interplay among 
PA, cardiovascular fi tness (CVF) and fatness with tHcy 
concentrations in childhood and adolescence are not 
clear. In a small sample of  Spanish adolescents from the 
AVENA study (Alimentación y Valoración del Estado 
Nutricional de los Adolescentes) an inverse association 
between tHcy and CVF was observed in females (21). In 
contrast, results from the Swedish part of  the European 
Youth Heart Study (EYHS) did not support these previ-
ous fi ndings (22). Thus, the purpose of  this study was 
to examine the association of  tHcy concentrations with 
objectively assessed PA, CVF and fatness after control-
ling for potential confounders in a large sample of  Euro-
pean adolescents.
PARTICIPANTS AND METHODS
Participants, recruitment and study design. The HEL-
ENA-CSS study (HEalthy Lifestyle in Europe by Nutrition 
in Adolescence) was a multi-centre cross-sectional study 
aiming to obtain reliable and comparable data from a 
random sample of  3,528 European adolescents of  10 
different cities aged between 12.5 and 17.5 y on a broad 
battery of  nutrition and health-related parameters 
(23, 24). Selection of  cities was based on two criteria: 
regional distribution and presence of  an active research 
group assuring suffi cient expertise and resources to 
successfully perform epidemiological studies. Within 
the study, Stockholm (Sweden) represented Northern 
Europe, Athens and Heraklion (Greece), Rome (Italy) 
and Zaragoza (Spain) Southern Europe, Pécs (Hun-
gary) Eastern Europe, Gent (Belgium) and Lille (France) 
Western Europe, and Dortmund (Germany) and Vienna 
(Austria) Central Europe. Reliable and objective data 
concerning age and gender were obtained by analysing 
complete school classes. On the city level, diversity of  
the sample with respect to cultural and socioeconomic 
aspects was achieved by performing a random propor-
tional distribution of  all schools taking into account 
the site of  the school (district/zone of  the city) and the 
type of  school (public or private). One partner (Gent) 
centrally performed for all study centres the school and 
class random selection procedure, including the subset 
of  classes for blood sampling. In case a selected school 
refused its participation, a school with comparable 
characteristics from a list of  substitutes was chosen. The 
sample size of  3,528 adolescents was estimated using 
body mass index (BMI; confi dence level of  95%, and 
a0.3 error). One-third of  the classes was randomly 
selected for blood collection, resulting in a total of  1,089 
(53% females) blood samples for the subsequent clinical 
biochemistry assays. Sixty-three per cent of  the total 
sample (n3,528) had valid data on cardiorespiratory 
fi tness and physical activity, resulting in a fi nal sample 
of  2,213 adolescents (53.8% females), for whom blood 
analyses were available for 713 (55.3% females).
Exclusion criteria were limited to subjects who were 
not able to speak the local language, subjects partici-
pating simultaneously in another clinical trial, subjects 
aged 12.5 or 17.5 y and subjects having suffered 
from acute infection 1 wk before the visit. Exclusions 
from the study were done a posteriori, without the 
knowledge of  the affected subjects, in order to avoid 
non-desired situations. All protocols and informed con-
sents for this study were reviewed and approved by an 
Ethics Review Committee in each country according to 
the Declaration of  Helsinki 1964 (revision of  Edinburgh 
2000), Convention of  Oviedo (1997), the Good Clinical 
Practice, and the legislation about clinical research in 
humans in each of  the participating countries. Informed 
written consent was obtained from subjects and parents 
or guardians. A complete description of  ethical issues 
and good clinical practice within the HELENA-CSS is 
provided elsewhere (25).
Prior to the start of  the HELENA-CSS all methods 
were tested in a pilot study to assure an optimal sam-
pling procedure and to optimise transport logistics and 
analytics.
Medical examination and blood sampling. Prior to the 
study day, participants were asked to abstain from eat-
ing and drinking after 8 p.m. On the study day, a medi-
cal doctor visited the school classes and asked all par-
ticipants for medical history and acute diseases. A blood 
sampling questionnaire was used to assess fasting sta-
tus, acute infections, allergies, smoking, vitamin and 
mineral supplements, and medication. Maturity was 
assessed by means of  Tanner stage (26). Medical data 
and all information were recorded in a case report form 
for each participant.
Blood sampling generally took place between 8 and 10 
a.m. Approximately 30 mL of  blood was collected from 
an antecubital vein in serum and heparin monovettes® 
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(Sarstedt AG & Co., Nümbrecht, Germany). Then, break-
fast was offered to all participants.
Sample pre-treatment and transport. The blood sam-
pling procedure within the HELENA-CSS was described 
in detail by Gonzalez-Gross et al. (27). Briefl y, serum gel 
tubes were centrifuged at 3,500 revolutions per min-
ute (rpm) for 10 min within 1 h after blood drawing for 
measuring creatinine. For the measurement of  folate, 
cobalamin, and tHcy heparin gel tubes were immedi-
ately placed on ice and centrifuged at 3,500 rpm for 
10 min within 30 min after blood drawing. Within 24 h 
the supernatant of  heparin was transported at a stable 
temperature of  4–7˚C while serum was transported at 
room temperature to the central laboratory in Bonn. 
All samples were stored at 80˚C until withdrawn for 
bunched analyses.
Biochemical and genetic analyses. The biochemical 
analyses of  folate, cobalamin, and tHcy were done with 
the use of  Immulite 2000 (DPC Biermann GmbH, Bad 
Nauheim, Germany). The intra- and interassay coeffi -
cients of  variation were 5.4% and 8.1% for folate, 5.0% 
and 12.7% for cobalamin, and 7.1% and 10.7% for 
tHcy. Creatinine was measured on the Dimension RxL 
clinical chemistry system (Dade Behring, Schwalbach, 
Germany) with enzymatic methods using the manufac-
turer’s reagents and instructions. The intraassay coef-
fi cient of  variation of  the creatinine assay was 3.4%, 
while the interassay coeffi cient was 5.8%. The DNA 
was extracted from white blood cells with the Puregene 
kit (QIAGEN, Courtaboeuf, France). The SNP MTHFR 
677C/T was genotyped by Illumina (Eindhoven, Neth-
erlands) with Golden Gate assay with a 100% success 
rate. The genotype distribution of  the polymorphism 
respected the Hardy-Weinberg equilibrium (p0.17) in 
the sample.
Physical activity. A uni-axial accelerometer 
(ActigraphTM GT1M, Pensacola, FL) was used to assess 
PA. Adolescents were instructed to place the monitor 
underneath the clothing, at their lower back, using an 
elastic waist band and to wear it for 7 consecutive days. 
They were also instructed to wear the accelerometer at 
all times except during water-based activities and peri-
ods of  sleep. At least 3 d of  recording with a minimum 
of  8 h registration per day was set as an inclusion cri-
terion; the time-sampling interval (epoch) was 15 s. A 
measure of  total volume of  activity was expressed as the 
sum of  recorded counts per epoch divided by the total 
daily registered time in minutes. The time engaged in 
moderate PA and vigorous PA was calculated and pre-
sented as the average time per day during the entire 
recording. The time engaged at moderate PA [3–6 meta-
bolic equivalents (METs)] was calculated based upon 
a blanket cut-off  of  2,000 counts per minute (cpm)—
approximately equivalent to the intensity of  a brisk walk 
(4.5 km/h). Periods of  vigorous PA (6 METs) were 
based upon a blanket cut-off  of  4,000 cpm. In addition, 
the time spent in at least moderate intensity level activ-
ity (3 METs) was calculated as the total time spent in 
moderate and vigorous physical activity (MVPA, min/d). 
Each minute spent above the specifi c cut-off  was sum-
marised in the corresponding intensity level group.
Cardiovascular fi tness. CVF was assessed by the 20-m 
shuttle run test. Adolescents were instructed to run in 
a straight line and to pace themselves according to the 
audio signals emitted from a pre-recorded cassette tape. 
The initial speed was 8.5 km/h, which was increased 
by 0.5 km/h per minute (1 min equal to one stage). 
The tape used was calibrated over 1 min. The test was 
fi nished when the participant either failed to reach the 
end lines concurrent with the audio signals on two con-
secutive occasions or stopped because of  fatigue. CVF 
was recorded as the number of  stages completed (preci-
sion of  0.5 steps). In addition, to facilitate comparison 
with previous studies maximal oxygen consumption 
(VO2max, mL O2/kg/min) was estimated using the Léger 
equation (28).
Body composition measurements. The anthropometric 
methods used within the HELENA-CSS were described 
by Nagy et al. (29). Briefl y, body weight was measured 
in kg using a standard beam balance (Type SECA 861, 
UK, precision 100 g, range 0–150 kg). Height was mea-
sured in cm using a precision stadiometer (Type SECA 
225, precision 0.2 cm, range 70–200 cm). Body mass 
index was calculated with the equation weight in kg 
divided by height in m squared (kg/m2). Skinfold thick-
ness (triceps, biceps, subscapular, suprailiac, thigh, 
and calf) was repeatedly measured on the left side of  
the body using a Holtain caliper (Crymych, UK, range 
0–40 mm) and the mean calculated. Only adolescents 
providing data for the sum of  six skinfolds (hereafter 
referred to as ‘skinfold thickness’) were included for the 
analyses. Percent body fat was calculated with the use 
of  the following equation reported by Slaughter et al.:
fat (%)0.61  (triceps skinfold in mm  calf  skinfold 
in mm)  5.1 for females and fat (%)0.735  (triceps 
skinfold in mm  calf  skinfold in mm)  1 for males 
(30).
Evaluation and statistics analysis. Regarding the 
point mutation in the MTHFR gene at nucleotide posi-
tion 677, adolescents were identifi ed as carriers of  the 
homozygous for the wild-type allele (CC), heterozygous 
(CT), and homozygous for the variant allele genotype. 
Further, adolescents were classifi ed into supplement 
users and non-supplement users (questionnaires). 
Smoking behaviour was categorised into daily smoking, 
smoking at least once a week but not every day, smoking 
less than once a week, and non-smokers. The number of  
cigarettes per day was not considered.
All data analyses were performed by using the Statis-
tical Package for Social Sciences (SPSS) version 19.0 for 
Windows (SPSS Inc., Chicago, IL). A weighting factor 
was introduced in order to adjust the theoretical sam-
pling to the observed sample in function of  age and gen-
der. Descriptive statistics are shown as meanstandard 
deviation (SD) unless otherwise stated. p-values 0.05 
were considered as statistically signifi cant. Blood tHcy, 
folate, and cobalamin concentrations, levels of  CVF 
(stages and VO2max), and BMI were normalised by nat-
ural logarithm transformation. To test gender-specifi c 
differences as well as subgroups with MVPA 60 min/d 
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and 60 min/d, Student’s t-test was used for metric 
variables and the  2-test for categorical variables. A 
bivariate correlation analysis was performed to examine 
the associations among tHcy and PA (cpm and MVPA), 
CVF (stages and VO2max), and fatness (BMI, skinfold 
thickness, and body fat percentage) by gender. Separate 
multiple regressions were performed by gender to study 
the relation among tHcy and PA, fi tness and fatness 
after controlling for potential confounders: age, matu-
rity, folate, cobalamin, creatinine, smoking, supplement 
use, and MTHFR 677C/T.
RESULTS
Table 1 reveals the gender-specifi c characteristics of  
the study population (n713). Compared with females 
(n394; 55.3%), males presented signifi cantly higher 
tHcy and lower cobalamin concentrations (tHcy: males: 
7.64.1 vs females: 6.82.4 mol/L and cobalamin: 
males: 336.6130.2 vs females: 360.0149.5 pmol/L, 
t-test, p0.001), but folate concentrations were similar 
between genders (18.99.7 nmol/L). In our sample, 
40.1% of  males and 42.1% of  females were CC, 42.5% 
of  males and 40.6% of  females were CT, and 17.4% of  
males and 17.3% of  females were TT. Eleven percent of  
the adolescents smoked every day, 4% at least once a 
week, 5% less than once a week; 80% did not smoke. A 
vitamin and/or mineral supplement was taken by 11% 
of  the adolescents. Smoking behaviour and supplement 
use did not vary between genders.
Table 2 presents bivariate Pearson correlations 
among tHcy concentrations and PA (cpm and MVPA), 
CVF (stages and VO2max), BMI, skinfold thickness, and 
body fat. In females, CVF variables (stages: r0.118 
and VO2max: r0.102) were negatively and BMI 
(r0.100) was positively associated (p0.05) with 
tHcy. Table 3 shows the gender-specifi c relationship 
among tHcy and PA, fi tness, and fatness after control-
ling for age, maturity, folate, cobalamin, and creatinine 
concentrations, smoking, supplement use, and MTHFR 
677C/T polymorphism. In females, tHcy was positively 
Table 1. Gender-specifi c characteristics of  the HELENA participants.
Male (n319) Female (n394) p-value
Age in y (n) 14.81.2 14.81.1 0.657*
Maturity in stages% 0.008#
 I/II/III/IV/V 1.4/7.3/19.9/37.6/33.8 0/4.3/22.0/42.5/31.2
Body mass index in kg/m2 20.73.3 21.33.4 0.060*
Skinfold thickness in mm 75.739.0 103.235.9 0.001*
Body fat in% 18.49.6 26.17.0 0.001*
MTHFR 677C/T in%
 CC/CT/TT 40.1/42.5/17.4 42.1/40.6/17.3 0.596/0.545/0.798#
THcy in mol/L 7.64.1 6.82.4 0.005*
Cobolamin in pmol/L 336.6130.2 360.0149.5 0.001*
Folate in nmol/L 18.99.7 18.99.7 0.777
Physical activity in counts per minute 502.8168.4 387.0122.7 0.049*
Moderate and vigorous physical activity in min/d 69.125.0 51.420.4 0.001*
Cardiovascular fi tness in stages 7.02.6 3.51.9 0.001*
Cardiovascular fi tness in mL O2/kg/min 52.58.0 36.75.7 0.001*
Parameters are shown as meanSD.
* Student’s t-test.
#  2-test.
MTHFR: methylenetetrahydrofolate reductase, CC: homozygous for the wild-type allele, CT: heterozygous, TT: homozygous 
for the variant-type allele.
Table 2. Bivariate Pearson correlations between homocysteine and independent variables by gender.
Male (n319) Female (n394)
Pearson p-value Pearson p-value
Physical activity in counts per minute 0.026 0.641 0.083 0.095
Moderate and vigorous physical activity 0.103 0.069 0.080 0.120
Cardiovascular fi tness in stages 0.035 0.579 0.118 0.023
Cardiovascular fi tness in mL O2/kg/min 0.030 0.627 0.102 0.044
Body mass index in kg/m2 0.086 0.129 0.100 0.045
Skinfold thickness in mm 0.076 0.576 0.034 0.757
Body fat in% 0.010 0.861 0.064 0.214
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associated with PA expressed in MVPA (p0.05).
Table 4 summarizes results of  available studies exam-
ining the association of  physical activity, cardiovascular 
fi tness, and fatness with homocysteine.
DISCUSSION
Despite the numerous scientifi c studies performed in 
recent years in relation to tHcy and its association with 
various health indicator outcomes such as PA and CVF, 
comparable data in the general European adolescent 
population are scarce. To the best of  the authors’ knowl-
edge, this is the fi rst study aiming to examine these asso-
ciations in a large number of  individuals of  ten different 
European cities.
The main fi nding in this study is that after control-
ling for several potential confounders well established 
in the literature (age, maturity, folate, cobalamin, cre-
atinine, smoking, supplement use and MTHFR 677C/T 
genotype) (12–14), tHcy levels were signifi cantly infl u-
enced by moderate and vigorous PA in female European 
adolescents. In male European adolescents tHcy levels 
were not infl uenced by the studied modifi able factors. 
Although the associations found are not very strong, 
these results could help further studies. More studies are 
needed analysing more deeply the relationship among 
tHcy, PA and BMI, to be able to establish the clinical rele-
vance. Likewise, it was observed that tHcy levels, PA and 
CVF in males were signifi cantly higher than in females, 
while females showed higher cobalamin values than 
males (p0.05).
The association between PA and tHcy has been shown 
in a few studies; most of  them were carried out on adults 
and with equivocal results (31). Duration, intensity, and 
mode of  exercise appear to impact blood tHcy levels dif-
ferently (4), and may depend on individual fi tness levels 
and MTHFR gene (4). In a recent study with active male 
subjects (mean age 23.5 y) tHcy levels signifi cantly 
increased after both maximal and submaximal acute 
intensity exercise (32). Regarding children and adoles-
cents, the Swedish part of  the EYHS study (children: 
9–10 y (n301) and adolescents: 15–16 y (n379)) 
was the fi rst to examine the association between tHcy 
and PA (22). No signifi cant results were found (p0.30) 
for the total sample after adjustment for gender, puber-
tal development, socioeconomic status, folate intake, 
cobalamin intake, and MTHFR 677C/T genotype, 
but the results were not split by gender. As our results 
showed signifi cant tHcy differences by gender, data were 
analysed separately. A signifi cant positive association 
between tHcy concentrations and MVPA was found in 
female adolescents (p0.05, Table 3), but not in males. 
These data suggest that tHcy levels could be higher in 
very active female adolescents.
Fitness is an important marker for several health 
outcomes in young people like obesity, cardiovascular 
risk, and skeletal and psychological health (33). CVF is 
defi ned as the ability of  active skeletal muscle to utilise 
oxygen during exercise. Changes in tissues and systemic 
vasculature may deteriorate the physiological capac-
ity and subsequently may also negatively affect CVF. To 
some extent, elevated tHcy concentrations may contrib-
ute to these pathological changes by the generation of  
reactive oxygen species and impairment of  nitric oxide 
production and bioavailability (3). Regarding adoles-
cents, in previous studies, CVF was signifi cantly and 
inversely associated with tHcy concentrations in Span-
ish female adolescents from the AVENA Study (n80 
females, aged 14.61.4 y) (21). Similar results were 
obtained in our study with a larger sample of  European 
female adolescents (n394), confi rming that CVF is a 
way of  not stimulating tHcy metabolism in female ado-
lescents. In contrast, results from the EYHS did not indi-
cate a signifi cant association between tHcy and fi tness 
in children or adolescents (22). The difference between 
results from the AVENA as well as our study and the 
Swedish part of  the EYHS might be due to the smaller 
sample size located only in one country. Additionally, it 
must be considered that healthy children and adoles-
cents usually do not show cardiovascular pathologies.
To encourage an active lifestyle, the World Health 
Organisation and other international and national 
public health organisations propose that school-aged 
children should perform at least 60 min of  moderate 
to vigorous intensity PA each day to ensure a healthy 
development (16, 34). Male adolescents participating in 
the HELENA-CSS achieved these recommendations with 
Table 3. Standardised multiple regression coeffi cients (), standard error (SE), and semipartial correlation (sr) examining 
the association of  physical activity, cardiovascular fi tness, and fatness with homocysteine after controlling for age, matu-
rity, folate, cobalamin, and creatinine concentrations, smoking, supplement use, and MTHFR 677C/T polymorphism.
Males (n319) Females (n394)
 SE sr p-value  SE sr p-value
Physical activity in counts per minute 0.002 0.002 0.063 0.343 0.029 0.002 1.01 0.124
Moderate and vigorous physical activity 0.010 0.011 0.062 0.354 0.795 0.401 0.131 0.049
Cardiovascular fi tness in stages 0.015 0.008 0.128 0.051 0.278 0.345 0.053 0.222
Cardiovascular fi tness in mL O2/kg/min 0.246 0.149 0.019 0.100 0.096 0.107 0.059 0.370
Body mass index in kg/m2 0.042 0.181 0.139 0.818 0.062 0.074 0.055 0.405
Skinfold thickness in mm 0.042 0.000 0.055 0.585 0.012 0.000 0.011 0.864
Body fat in% 0.043 0.052 0.037 0.411 0.076 0.037 0.136 0.245
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69.125.0 min/d of  MVPA whereas females did not 
accomplish it (51.420.4 min/d of  MVPA). tHcy con-
centrations did not vary between groups achieving or 
not achieving these recommendations, neither in males 
nor in females.
Regarding body composition, associations between 
BMI and tHcy concentrations have been frequently 
investigated in adolescents as presented in Table 4. Osga-
nian et al. (35) found a positive association between 
tHcy concentrations and BMI in 3,524 adolescents aged 
13–14 y, but after adjustment for potential confound-
ers, particularly blood vitamin concentrations, which 
Table 4. Summarized results of  studies examining the association of  physical activity, cardiovascular fi tness, and fatness 
with homocysteine.
Author Methods Factor Results (tHcy)
De Laet et al. 
1999
n647, 5–19 y, Belgium, GMSD BMI n.s.
Gallistl et al. 
2001
3-wk weight loss intervention, 37 obese 
females and 19 obese males, 11.91.7 y
LBM , baseline LBM, p0.002
Bates et al. 
2002
NDNS, n1,193, 4–18 y, UK BMI n.s.
Shen et al. 
2002
Taipei Children Heart Study, n1,235, 
12–15 y, Taiwan, meanSD
BMI M: sign. corr.
Randeva et al. 
2002
intervention, 21 overweight women with 
polycystic ovary syndrome, 29.76.8 y, brisk 
walking 3 per week over 6 mo
PA baseline: 10.063.22 vs after exercise: 
7.361.96 mol/L, p0.001
Kuo et al. 2005 NHANES, n1,444, 20–49 y, multiple logistic 
regressions, adjustments include folate and 
vitamin B12 concentrations
CVF as continuous variable (p0.003). 
as quartiles (p0.001) 
as odds ratios (p0.001)
Brasileiro et al. 
2005
case control study, n239, 5–19 y, Brazil BMI n.s.
Mora et al. 
2006
Women’s Health Study, n27,158, 
54.77.1 y, quintiles of  PA, median
PA highest quintile (1,574 kcal/wk): 10.4 vs 
lowest quintile (145 kcal/wk): 10.8 mol/L, 
p0.001
odds ratios for the association of  quintiles of  
PA with tHcy concentrations, n.s.
Husemoen et al. 
2006
general lifestyle intervention, 1-y follow up, 
n915, 30–60 y
PA n.s.
Huemer et al. 
2006
n264, 2–17 y, Austria, meanSD BMI R0.09, p0.001, after adjustment p0.05
Ruiz et al. 2007 AVENA study, n156, 14.81.4 y, regression 
models included folate and vitamin B12 levels 
as well as MTHFR 677C/T genotype
CVF , in females, p0.007
Ruiz et al. 
2007b
EYHS, n680, 9–10 and 15–16 y, adjust-
ments for gender, maturity, socioeconomic sta-
tus, folate and vitamin B12 intake, and MTHFR 
677C/T genotype
PA
CVF
BMI
n.s.
n.s.
n.s.
Papandreou et 
al. 2007
n524, 6–15 y, Greece BMI n.s.
Joubert et al. 
2008
less active (420 min/wk, n40) compared 
with active (420 min/wk, n36) adults, 
265 y, mean (range)
PA low PA: 7.51.6 vs high PA: 7.71.6 mol/L, 
p0.36
extremely high PA (750 min/wk, n11): 8.6 
(6.1–12.3) vs extremely low PA (130 min/
wk, n9): 6.9 (2.9–9.1) mol/L, p0.001
Unt et al. 2008 currently active ex-athletes (n52) compared 
with sedentary ex-athletes (n25), 35–62 y
CVF active: 9.432.12 vs sedentary: 
12.324.49 mol/L, p0.001
Al-Tahan et al. 
2008
n165, 13–18.5 y, Spain, median (2.5th–
97.5th percentile)
BMI n.s.
Murakami et al. 
2011
434 Japanese adults (118 men and 316 
women), 23–85 y
PA n.s. adjusting for age, sex, and folate intake 
between groups according to PA category in all 
subjects
Maroto-Sánchez 
et al. 2013
n10, healthy males, 18–28 y acute PA signifi cant increase (p0.05) in serum tHcy 
concentrations after the maximal and sub-
maximal tests
PA: physical activity, CVF: cardiovascular fi tness, BMI: body mass index, MTHFR: methylenetetrahydrofolate reductase, n.s.: 
not signifi cant, : positively associated, : negatively associated.
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had the strongest effect, the association was no longer 
signifi cant. These fi ndings emphasize the importance 
of  adjusting for B-vitamin status when examining asso-
ciations between tHcy and other parameters. We found 
a positive association between tHcy and BMI only in 
females (p0.045), but adjusting for B-vitamin status 
and MTHFR 677C/T genotype. However, we did not 
fi nd any association between tHcy concentrations and 
fatness (expressed as skinfold thickness and% body fat). 
These results are in accordance with fi ndings reported 
by several European cross-sectional studies including 
the EYHS (22), the British National Diet and Nutri-
tion Survey (n922, 4–18 y) (36), a Belgian (n647, 
5–19 y) (37), a Spanish (n165, 13–18.5 y) (38) and a 
Greek study (n524, 6–15 y) (39), as well as a Brazilian 
case control study (n239, 5–19 y) (40).
The cross-sectional design of  the HELENA study does 
not allow the drawing of  causal conclusions. Some 
prospective longitudinal studies on the development of  
cardiovascular risk factors from adolescence to adult-
hood have been implemented; however, to date most 
of  these studies omitted the relatively new risk factor 
homocysteine.
Strengths of  the present study are the inclusion of  
a relatively large number of  adolescents and several 
potential confounders including the MTHFR 677C/T 
genotype. PA was objectively measured with acceler-
ometers as well as CVF being objectively measured by 
the 20-m shuttle run test, and therewith VO2max was 
estimated for a better comparability with other studies. 
The indirect measurement of  VO2max is feasible within 
epidemiologic studies: it is not only practical, time-effi -
cient, and low in cost and equipment requirements, but 
can also be performed on large numbers of  adolescents 
simultaneously (41). In addition to BMI, body composi-
tion was measured by skinfold thickness which is sug-
gested to be a better predictor of  body fatness in later life 
than BMI (42).
In conclusion, the results of  the present study sug-
gest that tHcy concentrations decrease with increas-
ing CVF and increase with increasing BMI in European 
female adolescents. Additionally, tHcy concentrations 
were positively associated with moderate and vigor-
ous PA in female European adolescents. However, these 
associations are weak and probably not relevant in clini-
cal practice. Likewise, variation in tHcy concentrations 
could not be explained by PA expressed in cpm, CVF, or 
parameters of  fatness in males. All in all, our results 
confi rm the equivocal relationship between tHcy con-
centrations and exercise, which must be further studied.
Disclosure
The content of  this paper refl ects only the authors’ 
view and the rest of  HELENA study members are not 
responsible for it. The writing group takes sole responsi-
bility for the content of  this article.
Acknowledgments
The HELENA study has taken place with the fi nancial 
support of  the European Community Sixth RTD Frame-
work Programme (Contract FOOD-CT-2005-007034). 
Additional support came in the form of  by grants from 
the Spanish Ministry of  Education (EX-2007-1124, 
EX-2008-0641, AP2006-02464; AGL2007-29784-E/
ALI; AP-2005-3827), the Spanish Ministry of  Economy 
and Competitiveness (RYC-2010-05957), Universidad 
Politécnica de Madrid (CH/018/2008), Swedish Council 
for Working Life and Social Research, the ALPHA study, 
a European Union-funded study, in the framework of  
the Public Health Programme (Ref: 2006120), and the 
Spanish Ministry of  Health: Maternal, Child Health and 
Development Network (number RD08/0072). The con-
tent of  this article refl ects only the authors’ views, and 
the European Community is not liable for any use that 
may be made of  the information contained therein.
The authors wish to thank Ms Petra Pickert for her 
contribution to laboratory work.
None of  the authors had any confl ict of  interests.
Contributions of  each author: MMG, LAM, MS, MJC, 
DM, KW, YM, PS and AK are co-responsible of  the design 
of  the HELENA study. JRR, MJC, MGG and JB are respon-
sible for the design of  the present study. JB, JRR, GP and 
JMA are responsible for statistical analysis. JB, JV, JRR, 
JMA, MGG, PS, GVR, MF, CB, GP and SGM are respon-
sible for the fi rst writing of  the manuscript. All authors 
contributed to the execution of  the HELENA CSS study, 
the data analysis and interpretation, and approved the 
manuscript in its current version.
HELENA Study Group
Co-ordinator: Luis A. Moreno.
Core Group members: Luis A. Moreno, Fréderic Got-
trand, Stefaan De Henauw, Marcela González-Gross, 
Chantal Gilbert.
Steering Committee: Anthony Kafatos (President), Luis 
A. Moreno, Christian Libersa, Stefaan De Henauw, Jackie 
Sánchez, Fréderic Gottrand, Mathilde Kersting, Michael 
Sjöstrom, Dénes Molnár, Marcela González-Gross, Jean 
Dallongeville, Chantal Gilbert, Gunnar Hall, Lea Maes, 
Luca Scalfi .
Project Manager: Pilar Meléndez.
1. Universidad de Zaragoza (Spain). Luis A. Moreno, 
Jesús Fleta, José A. Casajús, Gerardo Rodríguez, Concep-
ción Tomás, María I. Mesana, Germán Vicente-Rodrí-
guez, Adoración Villarroya, Carlos M. Gil, Ignacio Ara, 
Juan Revenga, Carmen Lachen, Juan Fernández Alvira, 
Gloria Bueno, Aurora Lázaro, Olga Bueno, Juan F. León, 
Jesús Mª Garagorri, Manuel Bueno, Juan Pablo Rey 
López, Iris Iglesia, Paula Velasco, Silvia Bel.
2. Consejo Superior de Investigaciones Científi cas 
(Spain). Ascensión Marcos, Julia Wärnberg, Esther 
Nova, Sonia Gómez-Martínez, Esperanza Ligia Díaz, 
Javier Romeo, Ana Veses, Mari Angeles Puertollano, 
Belén Zapatera, Tamara Pozo.
3. Université de Lille 2 (France). Laurent Beghin, 
Christian Libersa, Frédéric Gottrand, Catalina Iliescu, 
Juliana Von Berlepsch.
4. Research Institute of  Child Nutrition Dortmund, Rhe-
inische Friedrich-Wilhelms-Universität Bonn (Germany). 
Mathilde Kersting, Wolfgang Sichert-Hellert, Ellen 
BENSER J et al.52
Koeppen.
5. Pécsi Tudományegyetem (University of  Pécs) (Hun-
gary). Dénes Molnar, Eva Erhardt, Katalin Csernus, 
Katalin Török, Szilvia Bokor, Mrs. Angster, Enikö Nagy, 
Orsolya Kovács, Judit Répasi.
6. University of  Crete School of  Medicine (Greece). 
Anthony Kafatos, Caroline Codrington, María Plada, 
Angeliki Papadaki, Katerina Sarri, Anna Viskadourou, 
Christos Hatzis, Michael Kiriakakis, George Tsibinos, 
Constantine Vardavas Manolis Sbokos, Eva Protoyeraki, 
Maria Fasoulaki.
7. Institut für Ernährungs- und Lebensmittelwis-
senschaften-Ernährungphysiologie, Rheinische Friedrich 
Wilhelms Universität (Germany). Peter Stehle, Klaus 
Pietrzik, Marcela González-Gross, Christina Breidenas-
sel, Andre Spinneker, Jasmin Al-Tahan, Miriam Sego-
viano, Anke Berchtold, Christine Bierschbach, Erika 
Blatzheim, Adelheid Schuch, Petra Pickert.
8. University of  Granada (Spain). Manuel J. Castillo 
Garzón, Ángel Gutiérrez Sáinz, Francisco B. Ortega Por-
cel, Jonatan Ruiz Ruiz, Enrique García Artero, Vanesa 
España Romero, David Jiménez Pavón, Cristóbal Sán-
chez Muñoz, Victor Soto, Palma Chillón, Jose M. Here-
dia, Virginia Aparicio, Pedro Baena, Claudia M. Cardia, 
Ana Carbonell.
9. Istituto Nazionalen di Ricerca per gli Alimenti e 
la Nutrizione (Italy). Davide Arcella, Elena Azzini, 
Emma Barrison, Noemi Bevilacqua, Pasquale Buono-
core, Giovina Catasta, Laura Censi, Donatella Ciarapica, 
Paola D’Acapito, Marika Ferrari, Myriam Galfo, Cinzia 
Le Donne, Catherine Leclercq, Giuseppe Maiani, Bea-
trice Mauro, Lorenza Mistura, Antonella Pasquali, Raf-
faela Piccinelli, Angela Polito, Raffaella Spada, Stefania 
Sette, Maria Zaccaria.
10. University of  Napoli “Federico II” Dept of  Food 
Science (Italy). Luca Scalfi , Paola Vitaglione, Concetta 
Montagnese.
11. Ghent University (Belgium). Ilse De Bourde-
audhuij, Stefaan De Henauw, Tineke De Vriendt, Lea 
Maes, Christophe Matthys, Carine Vereecken, Mieke de 
Maeyer, Charlene Ottevaere, Inge Huybrechts.
12. Medical University of  Vienna (Austria). Kurt 
Widhalm, Sabine Dietrich.
13. Harokopio University (Greece). Yannis Manios, 
Eva Grammatikaki, Zoi Bouloubasi, Tina Louisa Cook, 
Sofi a Eleutheriou, Orsalia Consta, George Moschonis, 
Ioanna Katsaroli, George Kraniou, Stalo Papoutsou, 
Despoina Keke, Ioanna Petraki, Elena Bellou, Sofi a Tana-
gra, Kostalenia Kallianoti, Dionysia Argyropoulou, Kat-
erina Kondaki, Stamatoula Tsikrika, Christos Karaiskos.
14. Institut Pasteur de Lille (France). Jean Dallon-
geville, Aline Meirhaeghe.
15. Karolinska Institutet (Sweden). Michael 
Sjöstrom, Patrick Bergman, María Hagströmer, Lena 
Hallström, Mårten Hallberg, Eric Poortvliet, Julia Wärn-
berg, Nico Rizzo, Linda Beckman, Anita Hurtig Wenn-
löf, Emma Patterson, Lydia Kwak, Lars Cernerud, Per 
Tillgren, Stefaan Sörensen.
16. Asociación de Investigación de la Industria Agroali-
mentaria (Spain). Jackie Sánchez-Molero, Elena Picó, 
Maite Navarro, Blanca Viadel, José Enrique Carreres, 
Gema Merino, Rosa Sanjuán, María Lorente, María José 
Sánchez, Sara Castelló.
17. Campden BRI (United Kingdom). Chantal Gil-
bert, Sarah Thomas, Elaine Allchurch, Peter Burguess.
18. SIK–Institutet foer Livsmedel och Bioteknik (Swe-
den). Gunnar Hall, Annika Astrom, Anna Sverkén, 
Agneta Broberg.
19. Meurice Recherche & Development asbl (Belgium). 
Annick Masson, Claire Lehoux, Pascal Brabant, Philippe 
Pate, Laurence Fontaine.
20. Campden & Chorleywood Food Development Insti-
tute (Hungary). Andras Sebok, Tunde Kuti, Adrienn 
Hegyi.
21. Productos Aditivos SA (Spain). Cristina Maldo-
nado, Ana Llorente.
22. Cárnicas Serrano SL (Spain). Emilio García.
23. Cederroth International AB (Sweden). Holger 
von Fircks, Marianne Lilja Hallberg, Maria Messerer
24. Lantmännen Food R&D (Sweden). Mats Lars-
son, Helena Fredriksson, Viola Adamsson, Ingmar 
Börjesson.
25. European Food Information Council (Belgium). 
Laura Fernández, Laura Smillie, Josephine Wills.
26. Universidad Politécnica de Madrid (Spain). Mar-
cela González-Gross, Jara Valtueña, Raquel Pedrero-
Chamizo, Gonzalo Palacios, Agustín Meléndez, Pedro J. 
Benito, Juan José Gómez Lorente, David Cañada, Ale-
jandro Urzanqui, Juan Carlos Ortiz, Francisco Fuentes, 
David Jiménez-Pavón, Ulrike Albers, Juan Mielgo Ayuso, 
Rosa María Torres, Paloma Navarro.
REFERENCES
1) Castro R, Rivera I, Blom H, Jakobs C, de Almeida IT. 
2006. Homocysteine metabolism, hyperhomocysteinae-
mia and vascular disease: An overview. J Inherit Metab 
Dis 29: 3–20.
2) Mangoni AA, Woodman RJ. 2011. Homocysteine and 
cardiovascular Risk: An old foe creeps back. J Am Coll 
Cardiol 58: 1034–1035.
3) Papatheodorou L, Weiss N. 2007. Vascular oxidant 
stress and infl ammation in hyperhomocysteinemia. 
Antioxidants Redox Signaling 9: 1941–1958.
4) Murakami H, Iemitsu M, Sanada K, Gando Y, Ohmori 
Y, Kawakami R, Sasaki S, Tabata I, Miyachi M. 2011. 
Associations among objectively measured physical 
activity, fasting plasma homocysteine concentration, 
and MTHFR C677T genotype. Eur J Appl Physiol 111: 
2997–3005.
5) Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E, 
Heart Outcomes Prevention Evaluation 2 Investigators. 
2009. Homocysteine-lowering therapy and stroke risk, 
severity, and disability: Additional fi ndings from the 
HOPE 2 trial. Stroke 40: 1365–1372.
6) Haan MN, Miller JW, Aiello AE, Whitmer RA, Jagust WJ, 
Mungas DM, Allen LH, Green R. 2007. Homocysteine, B 
vitamins, and the incidence of  dementia and cognitive 
impairment: Results from the Sacramento area latino 
study on aging. Am J Clin Nutr 85: 511–517.
7) Gjesdal CG, Vollset SE, Ueland PM, Refsum H, Meyer HE, 
Tell GS. 2007. Plasma homocysteine, folate, and vitamin 
B12 and the risk of  hip fracture: The hordaland homo-
Physical Activity and Homocysteine in Adolescents 53
cysteine study. J Bone Mineral Res 22: 747–756.
8) González-Gross M, Marcos A, Pietrzik K. 2001. Nutri-
tion and cognitive impairment in the elderly. Br J Nutr 
86: 313–321.
9) Papoutsakis C, Yiannakouris N, Manios Y, Papacon-
stantinou E, Magkos F, Schulpis K, Zampelas A, Mata-
las A. 2006. The effect of  MTHFR (C677T) genotype 
on plasma homocysteine concentrations in healthy 
children is infl uenced by gender. Eur J Clin Nutr 60: 
155–162.
10) Hustad S, Midttun Ø, Schneede J, Vollset SE, Grotmol 
T, Ueland PM. 2007. The methylenetetrahydrofolate 
reductase 677C→T polymorphism as a modulator of  a 
B vitamin network with major effects on homocysteine 
metabolism. Am J Human Genet 80: 846–855.
11) Yang QH, Botto LD, Gallagher M, Friedman JM, Sand-
ers CL, Koontz D, Nikolova S, Erickson JD, Steinberg K. 
2008. Prevalence and effects of  gene-gene and gene-
nutrient interactions on serum folate and serum total 
homocysteine concentrations in the united states: Find-
ings from the third national health and nutrition exami-
nation survey DNA bank. Am J Clin Nutr 88: 232–246.
12) Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg 
IH, Selhub J. 2001. Determinants of  plasma total homo-
cysteine concentration in the Framingham Offspring 
cohort. Am J Clin Nutr 73: 613–621.
13) Silaste M, Rantala M, Alfthan G, Aro A, Kesäniemi YA. 
2003. Plasma homocysteine concentration is decreased 
by dietary intervention. Br J Nutr 89: 295–301.
14) Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg 
IH. 1993. Vitamin status and intake as primary deter-
minants of  homocysteinemia in an elderly population. 
JAMA 270: 2693–2698.
15) Pedersen BK, Saltin B. 2006. Evidence for prescribing 
exercise as therapy in chronic disease. Scand J Med Sci 
Sports 16: 3–63.
16) Strong WB, Malina RM, Blimkie CJ, Daniels SR, Dish-
man RK, Gutin B, Hergenroeder AC, Must A, Nixon PA, 
Pivarnik JM. 2005. Evidence based physical activity for 
school-age youth. J Pediatr 146: 732–737.
17) Cuenca-García M, Ortega F, Ruiz J, González-Gross M, 
Labayen I, Jago R, Martínez-Gómez D, Dallongeville J, 
Bel-Serrat S, Marcos A. 2012. Combined infl uence of  
healthy diet and active lifestyle on cardiovascular dis-
ease risk factors in adolescents. Scand J Med Sci Sports 3: 
553–562.
18) Herrmann M, Wilkinson J, Schorr H, Obeid R, Georg T, 
Urhausen A, Scharhag J, Kindermann W, Herrmann W. 
2003. Comparison of  the infl uence of  volume-oriented 
training and high-intensity interval training on serum 
homocysteine and its cofactors in young, healthy swim-
mers. Clin Chem Lab Med 41: 1525–1531.
19) Borrione P, Rizzo M, Spaccamiglio A, Salvo RA, Dovio 
A, Termine A, Parisi A, Fagnani F, Angeli A, Pigozzi F. 
2008. Sport-related hyperhomocysteinaemia: A puta-
tive marker of  muscular demand to be noted for cardio-
vascular risk. Br J Sports Med 42: 894–900.
20) Joubert LM, Manore MM. 2008. The role of  physical 
activity level and B-vitamin status on blood homocyste-
ine levels. Med Sci Sports Exerc 40: 1923–1931.
21) Ruiz JR, Sola R, Gonzalez-Gross M, Ortega FB, Vicente-
Rodriguez G, Garcia-Fuentes M, Gutierrez A, Sjöström 
M, Pietrzik K, Castillo MJ. 2007. Cardiovascular fi tness is 
negatively associated with homocysteine levels in female 
adolescents. Arch Pediatr Adolesc Med 161: 166–171.
22) Ruiz JR, Hurtig-Wennlöf  A, Ortega FB, Patterson E, 
Nilsson TK, Castillo MJ, Sjöström M. 2007. Homocys-
teine levels in children and adolescents are associated 
with the methylenetetrahydrofolate reductase 677C 
T genotype, but not with physical activity, fi tness or
fatness: The European Youth Heart Study. Br J Nutr 97: 
255–262.
23) De Henauw S, Gottrand F, De Bourdeaudhuij I, Gonza-
lez-Gross M, Leclercq C, Kafatos A, Molnar D, Marcos A, 
Castillo M, Dallongeville J. 2007. Nutritional status and 
lifestyles of  adolescents from a public health perspec-
tive. the HELENA Project—Healthy lifestyle in Europe by 
nutrition in adolescence. J Public Health 15: 187–197.
24) Moreno L, De Henauw S, Gonzalez-Gross M, Kersting 
M, Molnar D, Gottrand F, Barrios L, Sjöström M, Manios 
Y, Gilbert C. 2008. Design and implementation of  the 
healthy lifestyle in Europe by nutrition in adolescence 
cross-sectional study. Int J Obes 32: S4–S11.
25) Beghin L, Castera M, Manios Y, Gilbert C, Kersting M, De 
Henauw S, Kafatos A, Gottrand F, Molnar D, Sjöström 
M. 2008. Quality assurance of  ethical issues and regu-
latory aspects relating to good clinical practices in the 
HELENA cross-sectional study. Int J Obes 32: S12–S18.
26) Tanner JM, Whitehouse RH. 1976. Clinical longitu-
dinal standards for height, weight, height velocity, 
weight velocity, and stages of  puberty. Arch Dis Child 51: 
170–179.
27) Gonzalez-Gross M, Breidenassel C, Gómez-Martínez 
S, Ferrari M, Beghin L, Spinneker A, Diaz L, Maiani G, 
Demailly A, Al-Tahan J. 2008. Sampling and processing 
of  fresh blood samples within a European multicenter 
nutritional study: Evaluation of  biomarker stability dur-
ing transport and storage. Int J Obes 32: S66–S75.
28) Leger L, Mercier D, Gadoury C, Lambert J. 1988. The 
multistage 20 metre shuttle run test for aerobic fi tness. J 
Sports Sci 6: 93–101.
29) Nagy E, Vicente-Rodriguez G, Manios Y, Beghin L, Iliescu 
C, Censi L, Dietrich S, Ortega F, De Vriendt T, Plada M. 
2008. Harmonization process and reliability assessment 
of  anthropometric measurements in a multicenter study 
in adolescents. Int J Obes 32: S58–S65.
30) Slaughter MH, Lohman TG, Boileau RA, Horswill CA, 
Stillman RJ, Van Loan MD, Bemben DA. 1988. Skinfold 
equations for estimation of  body fatness in children and 
youth. Hum Biol 60: 709–723.
31) Joubert LM, Manore MM. 2006. Exercise, nutrition, 
and homocysteine. Int J Sport Nutr Exerc Metab 16: 
341–361.
32) Maroto-Sánchez B, Valtueña J, Albers U, Benito PJ, 
González-Gross M. 2013. El ejercicio agudo aumenta 
las concentraciones de homocisteína en varones física-
mente activos. Nutrición Hospitalaria 28: 325–332.
33) Ortega F, Ruiz J, Castillo M, Sjöström M. 2008. Physical 
fi tness in childhood and adolescence: A powerful marker 
of  health. Int J Obes 32: 1–11.
34) Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Frank-
lin BA, Macera CA, Heath GW, Thompson PD, Bauman 
A. 2007. Physical activity and public health: Updated 
recommendation for adults from the American College 
of  Sports Medicine and the American Heart Association. 
Med Sci Sports Exerc 39: 1423–1434.
35) Osganian SK, Stampfer MJ, Spiegelman D, Rimm E, Cut-
ler JA, Feldman HA, Montgomery DH, Webber LS, Lytle 
LA, Bausserman L. 1999. Distribution of  and factors 
associated with serum homocysteine levels in children: 
BENSER J et al.54
Child and adolescent trial for cardiovascular health. 
JAMA 281: 1189–1196.
36) Bates CJ, Mansoor MA, Gregory J, Pentiev K, Prentice A. 
2002. Correlates of  plasma homocysteine, cysteine and 
cysteinyl-glycine in respondents in the British national 
diet and nutrition survey of  young people aged 4–18 
years, and a comparison with the survey of  people aged 
65 years and over. Br J Nutr 87: 71–79.
37) De Laet C, Wautrecht JC, Brasseur D, Dramaix M, Boey-
naems JM, Decuyper J, Kahn A. 1999. Plasma homocys-
teine concentration in a Belgian school-age population. 
Am J Clin Nutr 69: 968–972.
38) Al-Tahan J, Sola R, Ruiz JR, Breidenassel C, Garcia-Fuen-
tes M, Moreno LA, Castillo M, Pietrzik K, Gonzalez-Gross 
M. 2008. Methylenetetrahydrofolate reductase 677CT 
polymorphism and cobalamin, folate, and homocyste-
ine status in spanish adolescents. Ann Nutr Metab 52: 
315–321.
39) Papandreou D, Rousso I, Makedou A, Arvanitidou M, 
Mavromichalis I. 2007. Association of  blood pressure, 
obesity and serum homocysteine levels in healthy chil-
dren. Acta Paediatrica 96: 1819–1823.
40) Brasileiro R, Escrivao M, Taddei J, D’Almeida V, Ancona 
López F, Carvalhaes J. 2005. Plasma total homocyste-
ine in Brazilian overweight and non-overweight adoles-
cents: A case-control study. Nutrición Hospitalaria 20: 
313–319.
41) Ruiz JR, Ortega FB, Gutierrez A, Meusel D, Sjöström M, 
Castillo MJ. 2006. Health-related fi tness assessment in 
childhood and adolescence: A European approach based 
on the AVENA, EYHS and HELENA studies. J Public 
Health 14: 269–277.
42) Nooyens AC, Koppes LL, Visscher TL, Twisk JW, Kemper 
HC, Schuit AJ, van Mechelen W, Seidell JC. 2007. Ado-
lescent skinfold thickness is a better predictor of  high 
body fatness in adults than is body mass index: The 
Amsterdam growth and health longitudinal study. Am J 
Clin Nutr 85: 1533–1539.
